Please assess the completion status of the following clinical trial:

Trial Title: Lamotrigine for Symptoms of Geriatric Bipolar Depression

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 60 Years or older~* BP Disorder-I or II: Depressive episode (DSM -IV-TR; SCID-I/P)~* HAM-D score \> 18 (GRID-HAM-D 24-item version)~* Availability of an Informant is encouraged but not required for study participation~Exclusion Criteria:~* Chronic psychotic conditions, ie. schizophrenia, schizoaffective disorder, delusional disorder~* Contraindication to lamotrigine (Physician interview, medical assessment)~* Documented history of intolerance to lamotrigine~* Patients who have previously failed to respond to at least 12 weeks of treatment with lamotrigine~* Active substance dependence (SCID-I/P) or substance-related safety issues or PI concerns~* Mood Disorder Due to a General Medical Condition or Treatment (Physician interview)~* Rapid cycling (Physician interview): As defined in DSM-IV: At least 4 episodes of mood disturbance in the previous 12 months that meet criteria for a Major Depressive, Manic, Mixed or Hypomanic Episode. Episodes are distinguished either by partial or full remission for at least 2 months or by a switch to an episode of opposite polarity~* Dementia (by DSM-IV or brain degenerative diseases; Physician interview);~* Inability to communicate in English (i.e., interview cannot be conducted without an interpreter; subject largely unable to understand questions and cannot respond in English)~* Clinically significant sensory impairment (i.e., cannot see well enough to read consent or visually-presented material; cannot hear well enough to cooperate with interview; Physician interview)~* Recent history of cardiovascular, peripheral vascular events or stroke~* High risk for suicide (e.g., active SI or current intent or plan)~* Inpatient status

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open-Label Lamotrigine Treatment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).